NZ187115A - 2,4-diamino-5-(substituted benzyl)-pyrimidines and pharmaceutical compositions - Google Patents

2,4-diamino-5-(substituted benzyl)-pyrimidines and pharmaceutical compositions

Info

Publication number
NZ187115A
NZ187115A NZ187115A NZ18711578A NZ187115A NZ 187115 A NZ187115 A NZ 187115A NZ 187115 A NZ187115 A NZ 187115A NZ 18711578 A NZ18711578 A NZ 18711578A NZ 187115 A NZ187115 A NZ 187115A
Authority
NZ
New Zealand
Prior art keywords
pyrimidines
diamino
pharmaceutical compositions
substituted benzyl
benzyl
Prior art date
Application number
NZ187115A
Other languages
English (en)
Inventor
I Kompis
A E Wick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU77269A external-priority patent/LU77269A1/xx
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ187115A publication Critical patent/NZ187115A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C07C45/66—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups by dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ187115A 1977-05-05 1978-04-28 2,4-diamino-5-(substituted benzyl)-pyrimidines and pharmaceutical compositions NZ187115A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77269A LU77269A1 (enExample) 1977-05-05 1977-05-05
CH265078A CH642637A5 (en) 1977-05-05 1978-03-10 Benzylpyrimidines and process for their preparation

Publications (1)

Publication Number Publication Date
NZ187115A true NZ187115A (en) 1980-08-26

Family

ID=25691041

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187115A NZ187115A (en) 1977-05-05 1978-04-28 2,4-diamino-5-(substituted benzyl)-pyrimidines and pharmaceutical compositions

Country Status (19)

Country Link
US (2) US4203980A (enExample)
JP (1) JPS53137978A (enExample)
AT (1) ATA320578A (enExample)
BR (1) BR7802834A (enExample)
CA (1) CA1084498A (enExample)
DE (1) DE2819212A1 (enExample)
DK (1) DK143447C (enExample)
ES (1) ES469450A1 (enExample)
FI (1) FI781350A7 (enExample)
FR (1) FR2389611B1 (enExample)
GB (1) GB1583817A (enExample)
IL (1) IL54598A0 (enExample)
IT (1) IT1096292B (enExample)
MC (1) MC1194A1 (enExample)
NL (1) NL7804776A (enExample)
NO (1) NO781587L (enExample)
NZ (1) NZ187115A (enExample)
PT (1) PT67994B (enExample)
SE (1) SE7805186L (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
IT1138146B (it) * 1981-08-11 1986-09-17 Proter Spa Processo per la produzione della 2,4-diammino-(3,5-dimetossi-4-metos sietossi-benzil)-pirimidina
MX2008016008A (es) * 2006-06-16 2009-01-16 Lundbeck & Co As H Formas cristalinas de 4-[2-(4-metilfenilsulfonil)-fenil] piperidina con inhibicion combinada de la recaptacion de serotonina y norepinefrina para el tratamiento del dolor neuropatico.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) * 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
BE795023A (fr) * 1972-02-07 1973-08-06 Hoffmann La Roche Nouvelles benzylpyrimidines
US3985876A (en) * 1973-01-05 1976-10-12 Burroughs Wellcome Co. Chemotherapeutic solutions containing a sulphur and a salt of a 2,4-diamino-5-benzylpyrimidine
CH598231A5 (enExample) 1973-07-27 1978-04-28 Hoffmann La Roche
US3931181A (en) * 1973-07-27 1976-01-06 Hoffmann-La Roche Inc. 2,4-Diamino-5-benzylpyrimidines
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes

Also Published As

Publication number Publication date
US4254286A (en) 1981-03-03
FR2389611B1 (enExample) 1980-06-20
GB1583817A (en) 1981-02-04
IT1096292B (it) 1985-08-26
JPS53137978A (en) 1978-12-01
SE7805186L (sv) 1978-11-06
FI781350A7 (fi) 1978-11-06
MC1194A1 (fr) 1979-02-23
FR2389611A1 (enExample) 1978-12-01
DK195678A (da) 1978-11-06
BR7802834A (pt) 1979-02-13
US4203980A (en) 1980-05-20
PT67994B (en) 1980-05-05
PT67994A (en) 1978-06-01
ATA320578A (de) 1980-03-15
DK143447C (da) 1982-01-04
IT7823093A0 (it) 1978-05-05
NL7804776A (nl) 1978-11-07
IL54598A0 (en) 1978-07-31
DE2819212A1 (de) 1978-11-16
NO781587L (no) 1978-11-07
ES469450A1 (es) 1979-10-01
CA1084498A (en) 1980-08-26
DK143447B (da) 1981-08-24

Similar Documents

Publication Publication Date Title
IL64256A (en) 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them
NZ186197A (en) 3,4,5-trimethoxybenzene derivatives and pharmaceutical compositions
NZ188721A (en) Imidazolidines and pharmaceutical compositions
NZ188872A (en) 9-(-heteroarylamino-alkylamino)-erthromycins and pharmaceutical compositions
PH13563A (en) 2,6-diaminonebularines and compositions thereof
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
DE2860474D1 (en) Benzhydryl guanidine derivatives and pharmaceutical compositions
NZ188170A (en) Propenylamines and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
NZ187794A (en) 1-acyl-2-cynanoaziridines and immunestimulating pharmaceutical compositions
IL55845A (en) Quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL56078A0 (en) Novel condensed pyrimidine derivatives, their preparation and pharmaceutical compositions containing them
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ187989A (en) 1,4-di(substituted amino)-anthraquinones pharmaceutical compositions
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
NZ187617A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ187789A (en) 1,3-diazacyclopent-2-eno (2,1-b)(1-thia-o-azacycloalkanes)and pharmaceutical compositions
NZ188660A (en) 2-arylmino-hexahydro pyrimidines and -imidazolidines and fungicidal compositions
IL49972A (en) 2,4-diamino-pyrimidine derivatives their manufacture and herbicidal compositions containing them
NZ192096A (en) Pyrimidone derivatives and pharmaceutical compositions
NZ188531A (en) W-mercapto-propionamides and pharmaceutical compositions
NZ189300A (en) 3-aminoalkyl-thiazolidine-2,4-diones and pharmaceutical compositions
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
NZ186689A (en) Substituted bis-benzimidazolyl compounds and pharmaceutical compositions
IL54728A0 (en) Substituted 1,2,4-triazines and pharmaceutical compositions containing them